Backed by over a decade of experience in venture capital, the fund manager has successfully navigated investments across technology and healthcare sectors, primarily within North America and Europe. With a portfolio encompassing over 30 deals, their strategic operator-first approach has led to several notable exits, highlighting an emphasis on early-stage growth companies. Their investment thesis is data-driven, focusing on disruptive innovations that promise long-term scalability. Recognized for a hands-on, thematic investment style, they leverage deep industry insights to drive portfolio performance.